A.G.Bioteck Laboratories (India) Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 2.88 Cr
as on 08-07-2024
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 11.10 Cr
as on 08-07-2024
- Revenue 16.02%
(FY 2022)
- Profit -215.43%
(FY 2022)
- Ebitda -575.16%
(FY 2022)
- Net Worth -10.99%
(FY 2022)
- Total Assets 8.10%
(FY 2022)
About A.G.Bioteck Laboratories (India)
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 2.88 Cr.
The company has closed loans amounting to ₹11.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Abhinandan Punnam, Veera Punnam, and Punnam Rani serve as directors at the Company.
- CIN/LLPIN
U01112TG1992PLC014207
- Company No.
014207
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 May 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Ranga Reddy District, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does A.G.Bioteck Laboratories (India) Limited offer?
A.G.Bioteck Laboratories (India) Limited offers a wide range of products and services, including Fresh Flowers, Plants & Trees, Plant Tissue Culture, Tissue Culture Teak Plants, Outdoor Plant, Teak Plants, Forestry Plants, Ayurvedic Powder and Medicinal Herbs, Medicinal Plant, Tissue Cultured Plant.
Who are the key members and board of directors at A.G.Bioteck Laboratories (India)?
Executive Team (1)
VP
Veera Punnam
Managing DirectorAppointment Date: 01-Oct-2007
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of A.G.Bioteck Laboratories (India).
A.G.Bioteck Laboratories (India) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.02% increase. The company also saw a substantial fall in profitability, with a 215.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A.G.Bioteck Laboratories (India)?
In 2022, A.G.Bioteck Laboratories (India) had a promoter holding of 81.79% and a public holding of 18.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
29 years 7 months 
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Patiala Creation Date: 30 Jun 2012 | ₹7.00 Cr | Satisfied |
Ing Vysya Bank Limited Creation Date: 28 Jul 2010 | ₹2.50 Cr | Satisfied |
Idbi Bank Limited Creation Date: 21 Mar 2009 | ₹1.00 Cr | Satisfied |
How Many Employees Work at A.G.Bioteck Laboratories (India)?
Unlock and access historical data on people associated with A.G.Bioteck Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Nov 20, 2014, A.G.Bioteck Laboratories (India) has raised a total of ₹ 1.75 Cr, with the most recent deal valued at ₹ 2.06 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
